248 related articles for article (PubMed ID: 8922997)
1. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
Yang Y; Haecker SE; Su Q; Wilson JM
Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
[TBL] [Abstract][Full Text] [Related]
3. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues.
Yang Y; Su Q; Grewal IS; Schilz R; Flavell RA; Wilson JM
J Virol; 1996 Sep; 70(9):6370-7. PubMed ID: 8709265
[TBL] [Abstract][Full Text] [Related]
4. Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination.
Holst PJ; Ørskov C; Thomsen AR; Christensen JP
J Immunol; 2010 Apr; 184(8):4431-9. PubMed ID: 20212099
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration.
McClane SJ; Chirmule N; Burke CV; Raper SE
Hum Gene Ther; 1997 Dec; 8(18):2207-16. PubMed ID: 9449374
[TBL] [Abstract][Full Text] [Related]
6. Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig.
Guérette B; Vilquin JT; Gingras M; Gravel C; Wood KJ; Tremblay JP
Hum Gene Ther; 1996 Aug; 7(12):1455-63. PubMed ID: 8844205
[TBL] [Abstract][Full Text] [Related]
7. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
[TBL] [Abstract][Full Text] [Related]
8. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.
Jooss K; Yang Y; Fisher KJ; Wilson JM
J Virol; 1998 May; 72(5):4212-23. PubMed ID: 9557710
[TBL] [Abstract][Full Text] [Related]
9. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion.
DeMatteo RP; Markmann JF; Kozarsky KF; Barker CF; Raper SE
Gene Ther; 1996 Jan; 3(1):4-12. PubMed ID: 8929906
[TBL] [Abstract][Full Text] [Related]
11. Persistence in muscle of an adenoviral vector that lacks all viral genes.
Chen HH; Mack LM; Kelly R; Ontell M; Kochanek S; Clemens PR
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1645-50. PubMed ID: 9050832
[TBL] [Abstract][Full Text] [Related]
12. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
[TBL] [Abstract][Full Text] [Related]
13. Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats.
Lei D; Lehmann M; Shellito JE; Nelson S; Siegling A; Volk HD; Kolls JK
Hum Gene Ther; 1996 Dec; 7(18):2273-9. PubMed ID: 8953318
[TBL] [Abstract][Full Text] [Related]
14. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins.
Mays LE; Vandenberghe LH; Xiao R; Bell P; Nam HJ; Agbandje-McKenna M; Wilson JM
J Immunol; 2009 May; 182(10):6051-60. PubMed ID: 19414756
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.
Jooss K; Yang Y; Wilson JM
Hum Gene Ther; 1996 Aug; 7(13):1555-66. PubMed ID: 8864756
[TBL] [Abstract][Full Text] [Related]
17. Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors.
Kolls JK; Lei D; Odom G; Nelson S; Summer WR; Gerber MA; Shellito JE
Hum Gene Ther; 1996 Mar; 7(4):489-97. PubMed ID: 8800743
[TBL] [Abstract][Full Text] [Related]
18. Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency.
Petrof BJ; Lochmüller H; Massie B; Yang L; Macmillan C; Zhao JE; Nalbantoglu J; Karpati G
Hum Gene Ther; 1996 Oct; 7(15):1813-26. PubMed ID: 8894673
[TBL] [Abstract][Full Text] [Related]
19. DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle.
Chen HH; Mack LM; Choi SY; Ontell M; Kochanek S; Clemens PR
Hum Gene Ther; 1999 Feb; 10(3):365-73. PubMed ID: 10048389
[TBL] [Abstract][Full Text] [Related]
20. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
